Drug discovery in academia: Testing a potential new therapeutic for Rett syndrome

This episode outlines research focused on a new treatment strategy for Rett syndrome and related disorders, tests the hypothesis that there may be specific Rett syndrome populations that are most likely to respond effectively and safely to the treatment, and discusses specific biomarkers, like EEG, that might be used to test how the brain responds. 

VKC Researcher: Colleen Niswender, Ph.D., Research Associate Professor of Pharmacology; Director of Molecular Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery

Interviewer: Sheryl Anne Vermudez, Graduate Student in Pharmacology, Niswender laboratory